Candace Kendle, retired chairman and chief executive officer of Kendle
International Inc., has been elected to Emerson’s (NYSE:EMR) board of
directors, Chairman and CEO David N. Farr announced today.
Dr. Kendle co-founded Kendle International Inc., a global clinical
research organization that provides a wide range of services to the
global biopharmaceutical industry. She served as its chairman and CEO
from 1981 to 2011, growing Kendle International into a $450-million
public company and a leader in its industry, prior to its acquisition by
INC Research in 2011. Before founding Kendle International, she held
faculty positions with a number of leading universities, including the
University of Cincinnati College of Pharmacy, the University of
Pennsylvania School of Medicine, and the University of North Carolina
School of Medicine and School of Pharmacy.
“We are pleased that Dr. Kendle will be joining the board and we look
forward to her contributions and the benefits to Emerson that her keen
insights and strong global business experience will bring us,” said Farr.
Throughout her career, Kendle has been active with civic, educational,
and professional organizations. In 2008, she founded ReadAloud.org, a
non-profit organization aimed at improving childhood literacy by making
reading aloud for fifteen minutes per day the standard in childcare.
Dr. Kendle is a director of United Parcel Service (UPS), serving on the
company’s Audit Committee and as a healthcare expert to the board. Dr.
Kendle also previously served on the board of directors of H. J. Heinz
Company, and was a member of its Audit Committee and Corporate
Governance Committee. Additionally, she has served on the boards of such
organizations as the University of Cincinnati Foundation, the Harvard
Business School Alumni Association, and the National Underground
Railroad Freedom Center of the Smithsonian Institution.
Dr. Kendle holds a doctorate in pharmacy from the University of
Cincinnati, and completed her post-doctoral training at the Cincinnati
Children’s Hospital Medical Center and the University of North Carolina
School of Public Health.
She will serve on the Emerson Board’s Corporate Governance and
Nominating Committee and Finance Committee.
About Emerson
Emerson (NYSE: EMR), based in St. Louis, Missouri (USA), is a global
leader in bringing technology and engineering together to provide
innovative solutions for customers in industrial, commercial, and
consumer markets around the world. The company comprises five business
segments: Process Management, Industrial Automation, Network Power,
Climate Technologies, and Commercial & Residential Solutions. Sales in
fiscal 2013 were $24.7 billion. For more information, visit www.Emerson.com.
Copyright Business Wire 2014